Financial reports
Registration and prospectus
S-8
Registration of securities for employees
26 Jan 24
424B4
Prospectus supplement with pricing info
25 Jan 24
S-1MEF
Registration of additional securities for an S-1
24 Jan 24
S-1/A
IPO registration (amended)
23 Jan 24
8-A12B
Registration of securities on exchange
22 Jan 24
S-1/A
IPO registration (amended)
18 Jan 24
S-1
IPO registration
2 Jan 24
DRS/A
Draft registration statement (amended)
4 Dec 23
DRSLTR
Correspondence regarding draft registration statement
4 Dec 23
DRS
Draft registration statement
27 Oct 23
Proxies
No filings
Other
SEC STAFF
SEC staff action: Order
26 Jan 24
EFFECT
Notice of effectiveness
25 Jan 24
CERT
Certification of approval for exchange listing
24 Jan 24
CORRESP
Correspondence with SEC
22 Jan 24
CORRESP
Correspondence with SEC
22 Jan 24
CORRESP
Correspondence with SEC
5 Jan 24
CORRESP
Correspondence with SEC
2 Jan 24
UPLOAD
Letter from SEC
18 Dec 23
SEC STAFF
SEC staff action: Order
27 Nov 23
UPLOAD
Letter from SEC
27 Nov 23
Ownership
SC 13G/A
Decheng Capital Global Life Sciences Fund IV, L.P.
9 Apr 24
4/A
Xiangmin Cui
9 Apr 24
SC 13G
Kissei Pharmaceutical Co., Ltd.
14 Mar 24
SC 13G
TCG Crossover GP I, LLC
9 Feb 24
SC 13G
Decheng Capital Global Life Sciences Fund IV, L.P.
8 Feb 24
SC 13G
Longitude Capital Partners IV, LLC
5 Feb 24
SC 13G
Foresite Capital Fund V, L.P.
5 Feb 24
4
Vijay Kasturi
31 Jan 24
4
Corleen M. Roche
31 Jan 24
4
Hong Fang Song
31 Jan 24